Block Biosciences

Block Biosciences is developing first-in-class small molecule therapies combined with a companion diagnostic to prevent brain metastasis-an urgent and underserved cancer complication. Built on novel biology and predictive biomarkers, our proactive approach aims to block metastatic spread before it reaches the brain, extending survival and preserving quality of life for high-risk patients.